OliX Pharmaceuticals, Inc (KOSDAQ:226950)
South Korea · Delayed Price · Currency is KRW
164,800
+4,000 (2.49%)
Apr 10, 2026, 3:30 PM KST
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
|---|
| | | 17.06B | 9.32B | 3.67B | 2.47B | 1.13B | | |
| | | 83.09% | 153.66% | 48.50% | 118.90% | 274.28% | | |
| | | 17.06B | 9.32B | 3.67B | 2.47B | 1.13B | | |
| | | 83.09% | 153.66% | 48.50% | 118.90% | 274.28% | | |
Source: S&P Global Market Intelligence.